American Depositary Shares Archives | Be Korea-savvy
Uxin Limited Announces Pricing of Initial Public Offering

Uxin Limited Announces Pricing of Initial Public Offering

BEIJING, Jun. 27 (Korea Bizwire) — Uxin Limited (“Uxin” or the “Company”), the largest used car e-commerce platform in China, today announced the pricing of its initial public offering (“IPO”) of 25 million American depositary shares (“ADSs”), each representing three ordinary shares, at a price to the public of $9 per ADS. Concurrent with the [...]

Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

LONDON, Jun. 26 (Korea Bizwire) – Autolus Therapeutics plc (“Autolus”) (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the closing of its previously announced initial public offering in the United States of 10,147,059 American Depositary Shares (“ADSs”), representing 10,147,059 ordinary shares, at an initial public offering price of $17.00 [...]

TFI Tab Food Investments Launches Initial Public Offering

TFI Tab Food Investments Launches Initial Public Offering

ISTANBUL, Turkey and NEW YORK, Jan. 26 (Korea Bizwire) — TFI Tab Food Investments (“TFI”) today announced that it has commenced an initial public offering of 22,000,000  American Depositary Shares (“ADSs”), with each ADS representing 12 ordinary shares, including 4,500,000 ADSs to be sold by the Company and 17,500,000 ADSs to be sold by certain [...]

LexinFintech Holdings Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option

LexinFintech Holdings Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option

SHENZHEN, China, Jan. 7 (Korea Bizwire) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ:LX), a leading online consumer finance technology platform for educated young adults in China, today announced that the underwriters of the Company’s initial public offering (the “IPO”) have exercised their over-allotment option in full to purchase an additional 1,800,000 American depositary [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

LONDON, Dec. 5 (Korea Bizwire) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares (“ADSs”) representing ordinary shares of [...]

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering of [...]

RedHill Biopharma Prices Public Offering of its American Depositary Shares

RedHill Biopharma Prices Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 8 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the pricing of its previously announced underwritten public offering for [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 7 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it intends to offer its American Depositary Shares (“ADSs”), [...]

RedHill Biopharma Announces Withdrawal of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Withdrawal of Public Offering of its American Depositary Shares

TEL-AVIV, Israel, Nov. 2 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it has withdrawn the proposed underwritten public offering of its American [...]